Ledger.Open graph →
SEC Form D · filed September 18, 2024

CuraSen Therapeutics, Inc

Offering
$45.7M
Sold
$5.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Carlos, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Benjamin S. Potter · Menlo Park, CAExecRon S. Hunt · San Carlos, CADirectorAnthony P. Ford · San Mateo, CAExec · DirectorLoretta S. Tse, Ph.D · San Carlos, CADirectorPatrick S. Enright · San Mateo, CADirectorEugene Dozortsev · NEW YORK, NYExecKathleen S. Glaub · San Mateo, CADirectorSimon S. Tate, Ph.D · San Carlos, CADirector(General Partner) Headlands Capital Management, LLC · San Francisco, CAExecRon S. Hunt · San Carlos, CADirectorAnthony P. Ford · San Mateo, CAExec · DirectorLoretta S. Tse, Ph.D · San Carlos, CADirectorKathleen S. Glaub · San Mateo, CADirectorSimon S. Tate, Ph.D · San Carlos, CADirectorPatrick S. Enright · San Mateo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗